August 30, 2016
Hisamitsu Pharmaceutical said on August 29 that its Japan PI/III study on its analgesic transdermal patch HP-3150 containing NSAIDs (non-steroidal anti-inflammatory drugs) failed to demonstrate significantly better efficacy versus placebo in patients suffering from cancer pain. The Japanese patch drug...read more